A randomised, double blind, placebo-controlled trial of continuous subpectoral local anaesthetic infusion for pain and shoulder function following mastectomy.
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2016
At a glance
- Drugs Levobupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms SUBLIME; SUBLIME1
- 15 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 23 Aug 2015 Planned End Date changed from 14 Oct 2015 to 28 Jul 2015 as reported by United Kingdom Clinical Research Network.
- 14 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.